Mary Kay Extends Winning Streak With Fourth Year as #1 in Global Direct Selling Beauty
23.6.2026 15:03:00 EEST | Business Wire | Press release
Mary Kay Inc., the iconic beauty and entrepreneurship company, has once again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International, sustaining its legacy of excellence for the fourth consecutive year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260623487381/en/
Mary Kay Inc., the iconic beauty and entrepreneurship company, for the fourth year in a row has been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World by Euromonitor International. (Image Credit: Mary Kay Inc.)
“Earning the #1 global ranking from Euromonitor for the fourth consecutive year comes as a powerful endorsement of the impact of our Independent Beauty Consultants around the world who drive our success every day,” said Ryan Rogers, Chief Executive Officer of Mary Kay Inc. “Their entrepreneurial spirit, combined with our transformational investments in R&D and cutting-edge technology enable us to deliver high-performance skin and beauty solutions. This is the winning ticket that makes us one of the world’s most beloved consumer brands.”
Euromonitor International is the foremost provider of global business intelligence, market analysis, and consumer insights with over 50 years of conducting market research across more than 100 countries.
"Euromonitor International’s rankings represent the highest standard of global market performance, backed by rigorous, independent data and analysis,” stated Anthony Irwin, senior vice president of research at Euromonitor International. “Mary Kay’s continued leadership in direct selling beauty highlights its ability to deliver consistent value, quality, and relevance in a highly competitive global marketplace.”
Topping the charts:
- In addition to the Euromonitor recognition, Mary Kay consistently earns global accolades among top global beauty companies.
- In 2025 alone, Mary Kay garnered 41 beauty and industry awards around the world including being named #9 on the Forbes 2025 Best Brands for Social Impact2 list out of 3,900 brands.
- In 2026, Mary Kay ranked #20 in the Women’s Wear Daily Beauty Inc.’s 2025 Top 100 Beauty Companies.
- Forbes ranked Mary Kay #2 on its 2026 Best Customer Service3 list.
Global Innovation Powerhouse
Mary Kay continues to deliver high-performance skincare and color cosmetics through a combination of scientific innovation, consumer insights, and personalized service.
- Mary Kay has been issued over 1,600 patents worldwide in products, technologies, and packaging.
- Mary Kay’s Richard R. Rogers global Manufacturing and R&D Center in Texas can produce up to 1 million products per day.
- 64% of Mary Kay’s R&D scientists and 79% of Global Brand and Global Creative teams are women4.
Mary Kay’s portfolio includes award-winning and fan-favorite products such as:
- TimeWise® skincare line
- Clinical Solutions® advanced skincare
- TimeWise® 3D Foundations (Matte and Luminous)
- Oil-Free Eye Makeup Remover
- Ultimate Mascara™
- Unlimited® Lip Gloss
Mary Kay products are sold by best-in-class Independent Beauty Consultants in 40 markets worldwide who provide personalized service to customers in person and online at www.MaryKay.com (USA), and on social and digital media channels.
Did You Know?
Economic Impact of Direct Selling by the Numbers:
Globally:
- The global direct selling market is projected to reach approximately USD 815.4 billion by 2034, rising from an estimated USD 418.4 billion in 2024.5
In the U.S.:
- 73% of direct sellers in the U.S. are women.6
- $34.7 billion in retail sales generated through direct selling activities.7
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com. Find us on Facebook, Instagram, and LinkedIn, or follow us on X.
About Euromonitor International
Euromonitor International leads the world in global market intelligence into industries, companies, economies and consumers. With over 50 years at the cutting edge of the industry, we blend deep human expertise with AI technology and analytics, to deliver insights that drive confident, high-stakes decisions—at speed and scale. Our global network and proprietary data empower you to unlock growth opportunities and navigate change. We have specialist teams in 16 offices around the world and a network of on-the-ground analysts in over 100 countries, providing cultural and business nuances others miss. We research 210 countries and jurisdictions and 99.9% of the world’s consumers, helping our clients to make sense of global markets.
1 “Source Euromonitor International Limited; Beauty and Personal Care 2026 Edition, value sales at RSP, 2025 Data”
2 Haniya Rae, Contributor. (April 17, 2025). “Meet America’s Best Brands For Social Impact 2025.” https://www.forbes.com/sites/haniyarae/2025/04/17/meet-americas-best-brands-for-social-impact-2025/.
3 Alan Schwarz, (October 14, 2025). “2026 Best Customer Service.” https://www.forbes.com/lists/best-customer-service/.
4 Women and Leadership Representation at Mary Kay, May 2026.
5 Tajammul Pangarkar. (March 24, 2025). Direct Selling Market to Reach USD 815.4 Billion by 2034 at 6.9% CAGR. www.news.market.us/direct-selling-market-news
6 World Federation of Direct Selling Associations. (November 2025). 2024 Global Annual Direct Selling Statistical Data Report. https://wfdsa.org/wp-content/uploads/2025/12/WFDSA-STATS-Report-2024-2025-V1.pdf
7 DSEF 2025 US Growth & Outlook Study. DSEF 2026 US Economic Impact Report.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260623487381/en/
Contacts
Mary Kay Inc. Corporate Communications
newsroom.marykay.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnewsroom.maryk
ay.com%2F&esheet=54557800&newsitemid=20260623487381&lan=en-US&anchor=newsroom.ma
rykay.com&index=16&md5=4dc3f37431f0872603d0691f21039093
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Global Adds Andersen in Indonesia23.6.2026 16:30:00 EEST | Press release
Andersen Global strengthens its footprint in Southeast Asia as VDB Loi in Indonesia rebrands to Andersen in Indonesia, becoming the newest member firm to join the organization. Andersen in Indonesia provides tax and legal advisory services to multinational companies and foreign investors operating in the Indonesian market. The firm combines decades of market experience with a practical approach focused on delivering clear, tailored guidance across complex regulatory and cross-border matters. “Adopting the Andersen brand reflects our commitment to providing clients with high-quality, practical tax and legal advice supported by broader international collaboration,” said Tommy Hendharto Oetomo, managing partner of Andersen in Indonesia. “Clients operating in Indonesia require increasingly coordinated cross-border support. Becoming a member firm strengthens our ability to deliver that service with consistency and clarity.” “Indonesia remains an important market for organizations investing
Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies23.6.2026 16:30:00 EEST | Press release
Merck, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed at establishing a foundational portfolio in the promising field of rare genetic cardiomyopathies. This partnership aligns with the company’s commitment to address significant unmet medical needs in rare populations through targeted treatments. “Through our partnership with Saturnus Bio, we aim to fast track the development of innovative therapies for genetic cardiomyopathies through precision cardiology, targeting the rare population impacted by these conditions,” said David Weinreich, MD, Head of Research and Development and Chief Medical Officer, Healthcare business of Merck. “By leveraging Saturnus' expertise and cutting-edge approach, we can build upon our armed antibodies capabilities and explore novel directions to rapidly bring new, targeted treatments to patients.” “The launch of Saturnus through a foundati
Beyond the ‘Dumb Pipe’: How Agentic AI and Sovereign Networks Are Redefining Connectivity23.6.2026 15:46:00 EEST | Press release
The global connectivity market is shifting. With traditional European telecom growth slowing to 2-3% by 2029, businesses must adapt through Agentic AI, critical communications, and digital sovereignty. To remain competitive, operators should move beyond infrastructure toward an API-driven economy. These trends took center stage at Comarch User Group 2026. The conference hosted over 700 partners from 53 countries, including 201 connectivity experts, highlighting how companies can thrive in regulated environments. As telecom growth slows, demand for broader connectivity solutions across satellite, logistics, and critical communications is surging. Operators must abandon the old 4G “dumb pipe” model, where they act merely as network providers charging only for raw data transmission, for an API-driven economy with programmable network quality, securely integrating 5G with new satellite and IoT ecosystems. - Marcin Kaleta, CEO at Comarch Communications Putting Agentic AI in the Driver's Sea
Kobie 2026 Heart of Loyalty Report Reveals Growing Gap Between Consumer Expectations and Brand Loyalty Strategies23.6.2026 15:00:00 EEST | Press release
Kobie, a global leader in loyalty technology and services, today released its 2026 Heart of Loyalty Report, which surveyed both consumers and practitioners, revealing significant gaps between consumer expectations and brand loyalty strategies across AI adoption, data sharing, recognition, advocacy, and community engagement. Kobie's 2026 Heart of Loyalty Report found that: 57% of consumers are willing to engage with AI-powered brand experiences, yet 56% of loyalty practitioners believe customers are not ready for AI. 77% of consumers want recognition from brands, but only 55% feel seen as individuals. 72% of consumers say they would refer a brand without an incentive, yet many referral strategies remain heavily dependent on rewards. Rewards are the strongest driver of willingness to share personal data, yet only 65% of practitioners reward customers for sharing. Consumer expectations around loyalty are broadly consistent globally, but the factors that build trust, recognition and advoca
Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development23.6.2026 14:05:00 EEST | Press release
VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, today announced four strategic leadership hires that advance its mission to accelerate novel therapy approvals in complex disease areas, including cell and gene therapy, oncology, and rare disease. Building on its 30-year foundation in biostatistics and its recent acquisition of the medical writing and regulatory submission business of Certara, Veristat is deepening its scientific expertise and expanding its operational leadership to meet growing client demand. Dr. Zhaohui Su and Dr. Gil Fine join Veristat’s Strategic Drug Development Advisory team in biostatistical leadership roles, collaborating with Scott Tarrant, who has been named Executive Vice President of the team. In addition, Clint Wolfe joins Veristat as Chief Human Resources Officer (CHRO). After spending his early career in academia working on clinical trials at Harvard University, Dr. Su took a biostatistical leaders
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom